Case Study: Fortune 500 Biotech Company achieves better, faster decisions and reduced risk with Model N

Fortune 500 Biotech Company - Customer Case Study

This Fortune 500 biologics company—an innovator in recombinant DNA therapies operating in 40+ countries—was hindered by dozens of legacy platforms and growing complexity: global expansion, tighter regulation, competition from generics and biosimilars, and increasingly complex pricing strategies that were eroding margins. They needed a single global revenue management solution to consolidate systems, protect net revenue, and ensure compliance.

By implementing Model N’s revenue management cloud integrated with SAP, the company retired 35+ legacy systems, automated hundreds of thousands of price changes annually, and reduced billing errors and manual work. The deployment improved pricing controls, compliance, and visibility into net revenue, lowered IT total cost of ownership, and enabled consistent global processes (free goods, tenders, international reference pricing) across more than 40 countries.